Stay updated on Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page’s displayed software/revision version was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:40:10.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:52:37.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The study condition label was updated from Hepatocellular carcinoma to Adult hepatocellular carcinoma. This clarifies the trial's adult population focus.
    Difference
    0.0%
    Check dated 2026-04-02T15:37:42.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added MeSH term Hepatocellular carcinoma and a Genetic and Rare Diseases Information Center resource link; updated site revision to v3.5.0 (replacing v3.4.3).
    Difference
    0.2%
    Check dated 2026-03-19T06:33:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:24:15.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the previous v3.4.1 notice about government funding and operating status was removed.
    Difference
    0.4%
    Check dated 2026-02-11T12:34:58.000Z thumbnail image

Stay in the know with updates to Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sorafenib Post-Liver Transplant in Liver Cancer Clinical Trial page.